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Abstract
Background: Abnormalities of myelin integrity have been reported in obsessive-compulsive disorder (OCD) using multi-
parameter maps of diffusion tensor imaging (DTI). However, it was still unknown to what degree these abnormalities might
be affected by pharmacological treatment.
Objective: To investigate whether the abnormalities of white matter microstructure including myelin integrity exist in OCD
and whether they are affected by medication.
Methodology and Principal Findings: Parameter maps of DTI, including fractional anisotropy (FA), axial diffusivity (AD),
radial diffusivity (RD) and mean diffusivity (MD), were acquired from 27 unmedicated OCD patients (including 13 drug-naı ¨ve
individuals) and 23 healthy controls. Voxel-based analysis was then performed to detect regions with significant group
difference. We compared the DTI-derived parameters of 15 patients before and after 12-week Selective Serotonin Reuptake
Inhibitor (SSRI) therapies. Significant differences of DTI-derived parameters were observed between OCD and healthy
groups in multiple structures, mainly within the fronto-striato-thalamo-cortical loop. An increased RD in combination with
no change in AD among OCD patients was found in the left medial superior frontal gyrus, temporo-parietal lobe, occipital
lobe, striatum, insula and right midbrain. There was no statistical difference in DTI-derived parameters between drug-naive
and previously medicated OCD patients. After being medicated, OCD patients showed a reduction in RD of the left striatum
and right midbrain, and in MD of the right midbrain.
Conclusion: Our preliminary findings suggest that abnormalities of white matter microstructure, particularly in terms of
myelin integrity, are primari ly located within the fronto-striato-thalamo-cortical circuit of individuals with OCD. Some
abnormalities may be partly reversed by SSRI treatment.
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Introduction
Obsessive-compulsive disorder (OCD) is one of the most
common mental disorders in the general population, with a
prevalence rate of 2% to 3% [1]. The main clinical manifestations
seen in OCD patients are recurrent, intrusive and distressing
thoughts and/or repetitive behaviors, resulting in significantly
impaired occupational and social functioning [2]. However, the
neurobiological mechanisms of OCD are still unknown.
Previous structural and functional neuroimaging studies have
supported the role of fronto-striato-thalamo-cortical circuit
impairment in the pathogenesis of OCD. Rotge et al. [3] found
volumetric differences between OCD patients and control subjects
in the anterior cingulate cortex, orbitofrontal cortex and thalamus
using a meta-analysis. Another meta-analysis, conducted by
Whiteside et al. [4] using results from positron emission
tomography (PET) and single photon emission computed
tomography (SPECT), proved that significant differences of
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35889radiotracer uptake do exist between OCD patients and healthy
controls in the orbital frontal cortex and caudate nucleus.
Diffusion tensor imaging (DTI) is a non-invasive method that
maps the diffusivity of water molecules in tissue [5]. It is sensitive
to the orientation and integrity of the underlying white matter
fiber in vivo. Restricted by cell membrane and myelinlayers, the
diffusivity perpendicular to fiber direction (radial diffusivity, RD) is
lower than that along the length of the fiber (axial diffusivity, AD).
Fractional anisotropy (FA) is the most commonly used index to
detect this anisotropy, and is considered a sensitive marker of
changes in tissue microstructures. Another index, mean diffusivity
(MD), measures the average diffusivity in all directions, is
frequently used as a complement to FA.
Several DTI studies have investigated white matter abnormal-
ities in OCD patients relative to healthy subjects. These studies
have generally supported abnormalities of the fronto-striato-
thalamo-cortical loop in the pathogenesis of OCD. Within cortical
structures, higher FA and apparent diffusion coefficient (ADC)
were observed in the medial frontal region [6,7], and lower FA was
found in the parietal lobe [6,8], left lingual gyrus and occipital lobe
white matter [8]. In the cingulum, lower FA was reported in the
anterior cingulated gyrus [8], right posterior cingulated gyrus [9]
and cingulated bundle [10],while Cannistraro et al. [11] showed
greater FA values in the left cingulum bundle and lower FA values
in the right cingulum bundle. Yoo et al. [12] have reported higher
FA in the corpus callosum, while Nakamae et al. [13] found
smaller FA in the anterior body of the corpus callosum. Saito et al.
[14] showed FA reduction in the rostrum of the corpus callosum
and Garibotto et al. [10] also reported lower FA in the splenium of
the corpus callosum and altered principal diffusion direction
(PDD) along the corpus callosum. Greater FA measures were
found in the left anterior limb of internal capsule [11], white
matter around the right caudate [12] and bilateral semioval center
[7]. However, the results of these studies were inconsistent and
most of the studies used FA alone as a marker for studying white
matter abnormality.
Recent debates have focused upon the interpretation of DTI
parameters, suggesting that FA alone is insufficient for character-
izing changes in tissue microstructure [15,16]. Axial diffusivity and
radial diffusivity have been proposed as a more specific markers
for axonal and myelin injury, respectively [17]. Increased RD
without significant changes in AD was found in the demyelinated
mouse brain [18,19]. In recent human studies, these parameters
were used in combination with FA to investigate white matter
microstructure in schizophrenia [20–24], depression [25] and
autism [26,27]. These studies found increased RD and insignif-
icant changes in AD, suggesting deficits in myelination. However,
a recent report has suggested caution in interpreting changes of the
axial and radial diffusivities [28].
To our knowledge, only one OCD study has employed FA, RD
and AD measures [29]. This study found myelin abnormalities
represented by increased RD and normal AD in the body of the
corpus callosum. However, this study had a cross-sectional design
and 10 of the 21 OCD patients were receiving stable doses of drug
treatments.
In the current study, we employed the DTI technique to study
white matter abnormality in OCD patients using multiple
parameters including FA, AD, RD and MD. These parameters
were compared for patients before and after 12-week Selective
Serotonin Reuptake Inhibitor (SSRI) pharmacotherapy. We
hypothesized that abnormalities of white matter microstructure
including myelin integrity would be found in OCD patients. We
also predicted that sufficient medication would normalize the
changes in white matter microstructure.
Methods
Ethics statement
After the study procedure had been explained to the
participants, written informed consent was collected from all
participants involved in the study. The research was approved by
the local institutional ethics board (Institutional Review Board of
Shanghai Mental Health Center, Shanghai Jiao Tong University
School of Medicine).
Participants
Twenty-seven patients with OCD and 23 healthy controls
participated in the study. All participants were Chinese and right
handed, and were generally matched for age, sex and education.
The OCD patients were recruited from an outpatient clinic at
Shanghai Mental Health Center, Shanghai, China. Inclusion
criteria for patients with OCD were as follows: age between 18
and 54; no less than 9 years in education; a DSM-IV diagnosis of
OCD; and being free of pharmacotherapy for at least 8 weeks
before baseline (13 of the 27 OCD patients were drug-naive).
Patients who presented with comorbid Axis I psychiatric disorders
and a history of neurologic disorders were excluded. Two OCD
patients who fulfilled inclusion criteria refused to participate in the
MRI scanning. They were not counted within the OCD sample
total of 27. Control participants were recruited through local print
advertising. Inclusion criteria for the healthy controls were: age
between 18 and 54; no less than 9 years in education; no DSM-IV
Axis I diagnosis; and absence of a history of neurologic disorders.
A trained psychiatrist interviewed all participants with the Mini-
International Neuropsychiatric Interview (M.I.N.I.) for DSM-IV
(Diagnostic and Statistical Manual of Mental Disorders, 1994)
Axis I mental disorders. The obsessive-compulsive symptoms of
each participant were assessed using the Yale-Brown Obsessive
Compulsive Scale (Y-BOCS). We applied the Hamilton Anxiety
Rating Scale (HAMA, 14 items) and Hamilton Depression Rating
Scale (HAMD, 24 items) to measure participants’ anxiety and
depression symptoms respectively.
There were no significant differences between the 27 patients
and the 23 controls in age (t=21.62, df=48, p=0.11), gender
(x
2=0.03, df=1, p=0.87) or education (t=20.62, df=48,
p=0.52). OCD patients showed higher mean HAMA scores
(t=12.13, df=48, p,0.001) and mean HAMD scores (t=9.00,
df=48, p,0.001) than did the healthy controls (Table 1). There
were no significant differences between the 13 drug-naive and 14
previously medicated OCD patients in terms of age (t=0.42,
df=25, p=0.68), gender (x
2=0.22, df=1, p=0.88), education
(t=20.52, df=25, p=0.61), age at onset (t=0.93, df=25,
p=0.36), illness duration (t=20.53, df=25, p=0.61), mean Y-
BOCS scores (t=0.31, df=25, p=0.76), mean HAMA scores
(t=0.79, df=25, p=0.44) or mean HAMD scores (t=1.35,
df=25, p=0.19) at baseline (Table 1).
Pharmacotherapy
After receiving clinical feature measurements and DTI scans at
baseline, 15 of the 27 OCD patients agreed to accept SSRI
treatment only (6 of 15 OCD patients were drug-naive). The
decision as to the specific SSRI drug to be used was made by
psychiatrists on an individual basis, according to the needs of the
patient. SSRI medication included fluvoxamine, 6 patients;
fluoxetine 4; sertraline 3; and paroxetine, 2. Medium doses of
SSRIs were used within the study in order to balance the effect of
medication and potential side effects. Fluvoxamine and sertraline
treatments were started at the dose of 50 mg once daily and
increased to 150 mg once daily across a period of 6 weeks in
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maintained until the end of the 12-week pharmacotherapy.
Fluoxetine and paroxetine treatments were started at 20 mg/day
and increased to 40 mg/day across a period of 4 weeks by 20 mg
increments. The maximum dose of 40 mg/day was maintained
until the end of the 12-week pharmacotherapy. We used the
Asberg Rating Scale for Side Effects (SERS) to assess the side
effects every 4 weeks. None of the patients dropped out or
experienced severe side effects during SSRI treatment.
MRI acquisition setting
We scanned OCD patients for DTI data before and after 12-
week SSRI treatments. Healthy controls were scanned according
to the same time frame as the patients at baseline. All data were
acquired using a 1.5T magnetic resonance (MR) scanner (General
Electric Medical Systems, Milwaukee, WI, USA). Axial T1-
weighted imaging was conducted before the DTI scan in order to
quickly locate obvious lesions of cerebral parenchyma. A total of
26 DTI volumes were acquired, including 25 volumes applied
with diffusion gradient along 25 non-colinear directions
(b=1000 s/mm
2), and one B0 volume without applying diffusion
gradient (b=0). For each volume, 24 continuous slices, each 5-
mm-thick, were collected on a 24 cm624 cm field of view, with
the following imaging parameters: repetition time (TR)=9000 ms,
echo time (TE)=105.5 ms, and matrix=128*128. The acquisi-
tion time was 4 min 12 sec for each participant.
Image processing
We adopted voxel-based analysis (VBA) in our study, which had
been frequently used in previous OCD studies [6–12]. All data
were processed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/),
and FSL (http://www.fmrib.ox.ac.uk/fsl/) on a Linux based
platform. The eddy current distortion was first corrected for each
participant’s DTI volume using the ‘‘eddycorrect’’ toolbox in FSL.
Then, a brain mask, which separated brain and non-brain regions,
was calculated from the B0 volume using the BET toolbox (FSL).
Restricted within this mask, a diffusion tensor was fitted for each
voxel in the brain image space using FSL’s DTIFit. FA, AD, RD
and MD maps were subsequently calculated.
Next, maps from the control group (23 participants) and patient
group before medication (27 participants) were normalized to a
B0-template for further statistical testing following a three-step
procedure. An optimal method [30] was used, which is able to
more closely match the subjects under investigation and the
specific MRI acquisition setting in this study. Initially, a
participant-specific B0 template was built with the data from the
23 controls. Each B0 volume was normalized to the SPM EPI
template using SPM8’s nonlinear coregistration method, with a
reslicing resolution of 26262m m
3. These normalized B0 volumes
were then averaged and smoothed with a 6-mm FWHM Gaussian
kernel to yield the B0 template. Thus the MRI acquisition setting
of the resulting B0 template is the same as those data of each
subject. Secondly, all original B0 volumes were again normalized
to this B0 template, and the resulting transformation parameters
applied to their corresponding FA, AD, RD and MD maps.
Finally, following a popularly used schema - described in a
previous study with OCD patients [9] - we smoothed all the
transformed parameter maps with a 6-mm FWHM Gaussian
kernel, ready for further statistical testing. In addition, because the
study was focused on white matter abnormality of OCD patients, a
white matter mask was created to restrict the search volume for
statistics. We first generated a probabilistic tissue map of white
matter from the template’s B0 image using a tool incorporated in
SPM, called ‘‘segment’’. As the voxel intensity of the probabilistic
map ranged from 0.0 to 1.0, we used 0.6 as a threshold to yield this
binary white matter mask. The value 0.6 means that the
probability of a voxel belonging to white matter is 60%, which
we believe is an appropriate threshold to create the binary mask.
To compare the DTI-derived parameters of the patients before
and after medication, FA, MD, AD and RD maps from the 15
patients after medication were also normalized to the standard
space. To minimize the normalization error, each B0 volume of
the post-medication patients was first coregisted to its correspond-
ing B0 volume - collected from the same patient before medication
- with the resulting transformation applied to its corresponding
FA, AD, RD and MD maps. Then the transformation from
patients’ B0 volumes before medication to B0 template were
applied to these coregisted parameter maps to bring them into the
final B0-template space. Finally, a 6-mm FWHM Gaussian
smoothing was performed on these normalized parameter maps.
Statistics
We performed a whole-brain voxel-based analysis using the
normalized and smoothed FA, AD, RD and MD maps for a 2-
sample group t-test, comparing the 23 control participants and 27
patients before medication. Voxels of T.2.674 (p,0.001,
uncorrected, cluster size.10 voxels; 2-tailed) were considered as
indicating significant difference between the patient and control
Table 1. The Demographics and Clinical Characteristics of the Baseline Participants.
Variable
OCD whole group
(n=27)
Drug-naı ¨ve OCD
subgroup (n=13)
previously medicated OCD
subgroup (n=14)
Control group
(n=23)
Age, mean6 SD, y 25.567.0 26.169.3 24.964.1 28.867.6
Sex, No. M/F 17/10 8/5 9/5 15/8
Education, mean 6 SD, y 14.062.9 13.763.1 14.362.8 14.663.7
age at onset, mean 6 SD, y 20.467.9 21.9610.1 19.165.2 -
illness duration, mean 6 SD, y 4.864.0 4.364.6 5.163.6 -
Total YBOCS score, mean 6 SD 22.064.9 22.364.7 21.765.4 0
Obsessive subscale 13.363.0 13.463.3 13.262.9 0
Compulsive subscale 8.764.5 8.964.3 8.564.8 0
HAMA score, mean 6 SD 12.864.3 13.565.0 12.163.6 1.061.8
HAMD score, mean 6 SD 12.465.4 13.966.1 11.164.5 1.462.3
doi:10.1371/journal.pone.0035889.t001
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based OCD studies [8,12]. The white matter mask was used to
confine the statistic only in the white matter region. Averaged
maps were created from the normalized FA, AD, RD and MD
data from all 50 participants, respectively. Then the corresponding
t-test results were superimposed onto the averaged maps, using
xjview (http://www.alivelearn.net/xjview8).
The mean FA values in regions which previously showed
significant FA difference were calculated for control participants,
patients before and patients after medication using the normalized
and smoothed FA maps. Similar calculations were also made for
AD, RD and MD. The values of these parameters were then
correlated to the clinical scores using Pearson’s partial correlation
analyses, adjusted with age as a controlling factor. A General
Linear Model repeated-measure analysis of covariance (ANOVA)
was used in the analysis of each DTI-derived parameter before
and after treatment. Pre and post-treatment and brain regions
with abnormal DTI-derived parameters were set as within-subject
factors. ANOVAs with least significant difference (LSD) post hoc
tests were used to compare regional DTI-derived parameter
changes before and after treatment in OCD patients. Independent
t-tests were employed in the analyses of group differences in
demographic variables between OCD patients and normal
controls, and in demographic and clinical features between
drug-naive and previously medicated OCD patients. Paired t-tests
were used to compare clinical variables before and after treatment
in OCD patients. The tests were two-tailed and the threshold of
statistical significance was set at p,0.05.
Results
DTI-derived parameters at baseline
The results indicate significantly decreased FA in patients
compared with healthy controls in the left medial superior frontal
gyrus, temporo-parietal lobe and middle occipital gyrus and
around the left striatum white matter. Significantly higher RD in
patients was shown in the same regions of the left medial superior
frontal gyrus, temporal lobe, occipital lobe and striatum that
investigated decreased FA. Three other brain areas - the left
insula, right frontal lobe and midbrain - demonstrated increased
RD and normal FA. Significantly higher AD in patients compared
with healthy controls was observed only in the right frontal lobe,
where RD was found to be higher while FA was normal.
Accompanied by increased RD, there is significantly increased
MD in OCD patients compared with healthy controls in the same
brain areas of left medial superior frontal gyrus, temporal lobe,
occipital lobe, insula and right frontal lobe and midbrain. These
regions are illustrated in Figure 1. Montreal Neurological Institute
(MNI) coordinates and cluster sizes of the findings are shown in
Table 2. Significantly higher FA and lower RD, AD and MD were
not shown in any part of the brain white matter in OCD patients
compared with healthy subjects.
To compare DTI-derived parameters of patients with and
without a history of medication, mean FA, RD, AD and MD
values were extracted in regions where significant differences had
been found previously between the patient and healthy groups. We
found no significant group difference in terms of mean FA, RD,
AD and MD values (Table 3).
The total Y-BOCS scores (r=0.40, df=24, p=0.04) and
compulsive subscale scores (r=0.50, df=24, p=0.01) were
positively correlated with FA in the left striatum. None of the
diffusion multi-parameters correlated significantly with HAMA,
HAMD, age at onset or illness duration.
Posttreatment changes in DTI-derived parameters
After 12 weeks of SSRI treatment, mean Y-BOCS scores, mean
HAMA scores and mean HAMD scores in OCD patients were 9.9
(SD=3.2), 6.4 (SD=3.9) and 5.5 (SD=2.6) respectively. This
demonstrates significant improvements of 54% (SD=16%)
(t=9.31, df=14, p,0.001), 50% (32%) (t=5.85, df=14,
p,0.001) and 45% (SD=28%) (t=4.34, df=14, p=0.001)
respectively.
To evaluate DTI-derived parameter changes in patients before
and after 12-week SSRI treatment, mean FA, RD, AD and MD
values were extracted in regions where significant differences had
previously been found between the patient and healthy groups.
The effect of pre and post-treatment in brain regions with
abnormal RD values was found to be statistically significant
(F=7.079, df=1,14, p=0.019). There was a significant pre and
post-treatment 6 brain regions with abnormal RD values
interaction (F=5.375, df=4,54, p=0.001). Although the effect
of pre and post-treatment in the brain regions with abnormal MD
values was not statistically significant (F=3.669, df=1,14,
p=0.076), the pre and post-treatment 6 brain regions with
abnormal MD values interaction was found to be significant
(F=6.869, df=3,43, p=0.001). As to the regional differences,
decreased RD was observed in the left striatum (baseli-
ne=0.639610
23 mm
2/s (SD=0.033), follow-
up=0.615610
23 mm
2/s (SD=0.021), p=0.026) and right mid-
brain (baseline=0.783610
23 mm
2/s (SD=0.064), follow-
up=0.742610
23 mm
2/s (SD=0.054), p=0.044). Decreased
MD was also found in the right midbrain (baseli-
ne=0.947610
23 mm
2/s (SD=0.066), follow-
up=0.900610
23 mm
2/s (SD=0.053), p=0.019) (Figure 2). No
significant changes in DTI-derived parameters were found in the
left medial superior frontal gyrus, temporal lobe, occipital lobe,
insula and right frontal lobe (Table S1).
In order to reduce the possibility of potential type I errors
caused by multiple comparisons, we analyzed correlations between
symptom changes and DTI derived parameters, which were
greatly changed before and after treatment. Decreases in Y-BOCS
compulsive subscale scores were significantly correlated with the
RD (r=20.71, df=12, p=0.01) values in the left striatum, RD
(r=20.57, df=12, p=0.03) and MD (r=20.58, df=12,
p=0.03) in the right midbrain at baseline. The mean percentage
of RD in the left striatum changed by 4% and RD and MD in the
right midbrain both changed by 5%. However, no significant
correlations were found either between percentage changes in
clinical symptoms and percentage changes in DTI-derived
parameters, or between baseline clinical symptoms and percentage
changes in DTI-derived parameters.
Discussion
This is the first DTI study using both multiple parameters and
unmedicated OCD patients. This study was therefore designed to
be exploratory, using a whole-brain analysis to provide a broad
perspective of the pathology found in this patient sample. Two
main findings emerged from this study. First, OCD patients
demonstrated abnormalities of white matter microstructure,
particularly in terms of myelin integrity in multiple sites of the
fronto-striato-thalamo-cortical loop. Second, these abnormalities
were not a result of previous medication use. Indeed, there are
indications that some abnormalities could be partly reversed by
SSRI treatment. The interesting findings emerging from this study
contribute to the identification of regions of interest relevant to
OCD research. At the same time, the data indicates possible
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35889Figure 1. Voxel-based analysis between 27 patients with obsessive-compulsive disorder and 23 healthy controls before
medication. The results were overlaid on mean images of corresponding diffusion tensor imaging (DTI) parameters. A. Fractional Anisotropy (FA)
decrease; B. Mean Diffusion (MD) increase; C. Axial diffusion (AD) increase; D. Radial diffusion (RD) increase; p,0.001 uncorrected and cluster size.10
voxels. No increased FA and decreased diffusion coefficients (AD, RD and MD) were found.
doi:10.1371/journal.pone.0035889.g001
Table 2. Areas of abnormal DTI-derived parameters in 27 patients with obsessive-compulsive disorder and 23 healthy controls
before medication.
Diffusion
parameter Region Peak coordinates* (x,y,z) Cluster size t value
FA Left medial superior frontal gyrus 210 52 16 29 3.79
Left striatum 226 26 22 55 4.36
Left temporo-parietal lobe 228 254 22 11 3.91
Left middle occipital gyrus 222 288 6 31 4.53
RD Left medial superior frontal gyrus 210 50 16 27 4.50
Left striatum 224 16 4 13 3.87
Left temporal lobe 234 252 18 29 3.77
Left fusiform gyrus, occipital lobe 226 274 26 12 3.59
Left insula 234 2 18 14 3.94
Right frontal lobe 34 14 20 17 4.00
Right midbrain 2 226 216 14 4.39
AD Right frontal lobe 34 8 18 71 4.44
MD Left medial superior frontal gyrus 210 50 16 12 4.13
Left temporal lobe 228 262 22 25 3.72
Left fusiform gyrus, occipital lobe 226 276 28 32 4.30
Left insula 234 2 18 12 3.78
Right frontal lobe 34 14 20 61 4.77
Right midbrain 2 226 216 10 4.10
*peak coordinateds represent the location of the maximum pixel values in standard Montreal Neurological Institute (MNI) space.
df=48; p,0.001 (uncorrected).
doi:10.1371/journal.pone.0035889.t002
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to ongoing research.
In the present study, abnormal DTI-derived parameters in
OCD patients were observed in the white matter including the left
medial superior frontal gyrus, temporo-parietal lobe, occipital
lobe, insula, right frontal lobe and midbrain and white matter
around the left striatum. These structures are located within
important brain regions relevant to the pathophysiology of OCD,
and indicate abnormalities primarily in the fronto-striato-thalamo-
cortical loop. Baseline DTI-derived parameters did not differ
between patients with and without medication history.
The prefrontal cortex is primarily involved in cognitive function
and emotional information processing in human beings. Both
structural and functional imaging studies have supported the
existence of abnormalities within the prefrontal cortex, particularly
the orbitofrontal cortex, in OCD patients [3,4,31]. However, two
studies reported higher FA and ADC in the medial frontal region
[6,7], which is inconsistent with our findings. In the study of
Menzies et al. [6], 23 of the 30 OCD patients had been prescribed
the SSRIs, clomipramine and quetiapine. In another study, 2 of 15
OCD patients had comorbid mood disorders and all patients were
taking drug treatments for OCD [7]. Yoo et al. have noted in their
study that white matter alterations may be partly reversible with
citalopram treatment [12]. Therefore, differences in the patient
sample may account in part for this inconsistency.
Table 3. Mean FA, RD, AD and MD values between drug-naive and previously medicated OCD patients.
Diffusion
Parameter Region
Drug-naı ¨ve patients
(n=13)
previously medicated
patients (n=14) t p
FA Left medial superior frontal gyrus 0.20060.015 0.19560.018 0.099 0.922
Left striatum 0.33460.029 0.33560.020 20.142 0.888
Left temporo-parietal lobe 0.31560.024 0.30560.026 0.986 0.334
Left middle occipital gyrus 0.25060.027 0.24360.042 0.507 0.617
RD Left medial superior frontal gyrus 0.75660.038 0.74460.061 0.599 0.554
Left striatum 0.63860.029 0.62760.038 0.829 0.415
Left temporal lobe 0.66060.023 0.66160.051 20.048 0.962
Left fusiform gyrus, occipital lobe 0.65260.060 0.65160.059 0.055 0.957
Left insula 0.64060.021 0.62360.041 1.289 0.209
Right frontal lobe 0.64260.038 0.61860.033 1.730 0.096
Right midbrain 0.78360.050 0.78360.064 0.002 0.998
AD Right frontal lobe 1.00260.026 0.98660.045 1.132 0.268
MD Left medial superior frontal gyrus 0.85060.034 0.83760.061 0.666 0.512
Left temporal lobe 0.80060.022 0.80060.053 20.014 0.989
Left fusiform gyrus, occipital lobe 0.83060.058 0.82060.063 0.418 0.680
Left insula 0.75460.022 0.73960.043 1.089 0.287
Right frontal lobe 0.75960.032 0.74060.030 1.611 0.120
Right midbrain 0.94360.053 0.94660.067 20.093 0.926
The units of radial diffusivity (RD), axial diffusivity (AD) and mean diffusivity (MD) is 10
23 mm
2/s.
doi:10.1371/journal.pone.0035889.t003
Figure 2. Regional radial diffusivity and mean diffusivity in follow-up patients before and after treatment and healthy controls. Blue
bar represents follow-up patients at baseline (N=15), red bar represents follow-up patients after treatment (N=15), yellow bar represents healthy
controls (N=23). Error bars is 95% CI (confidence intervals). The units of radial diffusivity (RD) and mean diffusivity (MD) is 10
23 mm
2/s.
a Significant
difference between obsessive-compulsive disorder patients and healthy controls (p,0.001, ANOVA with least significant difference post hoc test).
b
Significant difference between follow-up patients with obsessive-compulsive disorder before and after treatment (p,0.05, ANOVA with least
significant difference post hoc test).
doi:10.1371/journal.pone.0035889.g002
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structures, beside the frontal lobe, participate in the frontal-
subcortical circuit [32]. The temporo-parietal junction is a
complex sensory cortical area, which is involved in perception
and awareness. The fusiform gyrus is thought to be an occipito-
temporal gyrus. The fusiform gyrus and the occipital lobe are
involved in visual processing, face and body recognition, and word
identification. Koprivova et al. [33] found total white matter
volume reduction, with marked reduction particularly in the right
temporo-parieto-occipital and left middle temporal gray matter in
OCD patients. Furthermore, functional magnetic resonance
imaging studies have shown abnormalities in the temporal lobe,
parietal lobe and occipito-temporal region [34,35]. Similar
findings have been reported by Szeszko et al. [8] and Menzies et
al. [6], suggesting that OCD patients possess lower FA in the
bilateral parietal and left occipital lobe. No other DTI studies have
reported temporal lobe abnormalities in OCD. The insular has
several functions, including interoceptive awareness, motor
control, homeostasis and emotional functioning. These functions
are all related to the symptoms of OCD. Pujol et al. [36] reported
that their sample of 72 OCD patients demonstrated reduced gray
matter volume in the medial frontal gyrus, the medial orbitofrontal
cortex and the left insulo-opercular region. One PET study
indicated a reduction of serotonin transporter binding in the
insular cortex in OCD patients [37]. Our study also found that
myelin integrity was damaged in the insular cortex in OCD
subjects.
The striatum forms a key region within the subcortical
structures involved in the pathophysiology of OCD, and is mainly
involved in the planning and modulation of movement pathways.
In contrast to our study, two studies have shown significantly
higher FA in the internal capsule and white matter in the area
superolateral to the right caudate among OCD patients [11,12].
The small sample size of these two studies may explain their
inconsistency with the results of our study. We also found that FA
variables were positively correlated with the severity of compulsive
symptoms in the left striatum. Ha et al. [9] also showed a positive
correlation between the Y-BOCS obsessive subscale scores and
mean FA values, with the suggestion that this relationship emerges
as a compensatory mechanism for neuronal alternations in the
anterior cingulate. A further two MRI studies have reported a
relationship between striatum volumes and severity of OCD
symptoms [36,38]. Our results support the proposal that the
striatum may be involved in the compulsive symptoms of OCD.
The neurons of the raphe nuclei are distributed along the
brainstem and midbrain and are closely related with the serotonin
system. Metabolic imaging studies including PET and SPECT
have shown decreased serotonin transporter availability in the
midbrain and brainstem of OCD patients [39–41]. In our study,
abnormal white matter microstructure was found in the right
midbrain of OCD patients as compared to healthy controls. No
other DTI studies have found midbrain abnormalities in OCD.
Further studies should be undertaken to investigate the relation-
ship between myelin integrity abnormalities and the serotonin
system in OCD patients.
The pathophysiological processes of decreased FA and/or
increased MD in OCD patients are indicative of white matter
microstructural abnormalities. Higher RD in combination with no
change in AD among OCD patients was found in the left medial
superior frontal gyrus, temporo-parietal lobe, occipital lobe,
striatum, insula and right midbrain, further suggesting that
disruptions of myelin integrity contributed to the white matter
abnormalities in these regions. This finding is supported by recent
genetic studies. There was biased transmission of polymorphisms
in the genes involved in myelination in OCD, such as myelin
oligodendrocyte glycoprotein (MOG) [42] and oligodendrocyte
lineage transcription factor 2 (OLG2) [43]. Atmaca et al. provided
further evidence that the MOG G511C (Val142Leu) polymor-
phism might be associated with changes in the total white matter
volume of OCD patients [44]. The results of these studies support
the existence of structural abnormalities of myelin in OCD. We
noticed higher AD along with higher RD and MD, and normal
FA in the right frontal lobe, which suggests a pattern of both
myelination and axonal deficits. A possible explanation is that
axial diffusivity occurs as an effective compensatory response when
the myelin integrity is impaired.
We also found that abnormal myelin integrity in the left
striatum and right midbrain of OCD patients was reversible by 12-
week SSRI therapy. Several imaging studies support the finding
that abnormalities of frontal-subcortical circuits in OCD patients
are partly improved after treatment [45–51]. In particular,
decreased activation within the left putamen [49] and increased
dysfunctional availability of serotonin transporter in the midbrain
[51] were found after medication in two studies. Yoo et al. further
identified that the white matter changes in the FA variable were
partly reversible in the right posterior thalamic radiation after 12
weeks of citalopram treatment in OCD patients [12]. There is no
direct study exploring the potential pharmacological roles of SSRI
on myelination. However, SSRIs are considered to have the effect
of neuroprotection and promote activation of Brain Derived
Neurotrophic Factor (BDNF) [52]. Xiao et al. proved that BDNF
could directly effect oligodendrocytes and increase central nervous
system myelination [53]. Interestingly, although we did not find
correlations between changes in DTI-derived values and clinical
symptoms, DTI-derived parameters before SSRI treatment were
significantly correlated with changes in compulsive symptoms.
Our findings suggest that baseline DTI-derived parameters in
several regions including the left striatum, right frontal lobe and
midbrain may be related to the clinical efficacy of SSRI.
Please note although the statistics conducted in this study was
uncorrected using a cluster of 10 voxels, we used a cruel p-value
threshold of ,0.001 to indicate statistical confidence. The use of a
small cluster size is in part due to the quality of DTI data collected
within this preliminary study. Further research based on this
preliminary study and using DTI data of improved image quality,
should be driven by carefully designed hypotheses with more
rigorous statistical standards.
Several other limitations also exist in the present study. One
problem for voxel-based analysis (VBA) is related to multiple
comparisons and, therefore, the potential for type I error. To limit
the impact of this on the final results, we used RD, AD and MD as
complementary measures to the FA result. Another major
shortcoming is that VBA is unable to directly provide indications
of abnormal connectivity between anatomical structures. Fiber
tracking techniques may present an appropriate option to deal
with this problem, and will form an aspect of future work following
this paper. Slight differences among the four SSRI drugs used in
the present study should be considered, although they are all
variations of SSRIs and share common pharmacological mecha-
nisms. There is a possibility that changes in DTI-derived
parameters in several brain regions before and after 12-week
SSRI treatment were related to the passage of time. Further
studies employing a ‘‘placebo-treated group’’ would help to tackle
this query.
In conclusion, our preliminary findings suggest that in OCD
abnormalities of white matter microstructure, particularly in terms
of myelin integrity, primarily affect the fronto-striato-thalamo-
cortical circuit, independent of previous medication history. These
White Matter in Obsessive-Compulsive Disorder
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35889abnormalities attest to the role of white matter in the pathophys-
iology of OCD. Some abnormalities may be partly reversed by
SSRI treatment.
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